← ANALYST RATINGS · TIPRANKS
Humana (HUM): analyst forecast and price target
Analyst consensus
Moderate Buy11 Buy5 Hold1 Sell
Ratings of 17 analysts in the last 3 months · top analysts only12-month forecast
Based on 17 price targets given in the last 3 months, the average target is $449, the highest $520, the lowest $280. The average is +8.6% from the last price of $413.
Analyst ratings 25
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Andrew Mok CFA★★★★★★★★★★#11840 · hits 51% · avg −4.8% | Barclays | $582 | Buy | +40.9% | Reiterated | 14.10.26on TipRanks 05:00 | +2.8%next day +0.8% | ↗ |
| AI xAi Medical - Healthcare PlansxAI Grok-4 | TipRanks - xAI | $403 → $457+13.4% | Hold | +10.6% | Reiterated | 13.10.26on TipRanks 11:05 | — | |
| AI DeepSeek Medical - Healthcare PlansDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $393 → $453+15.3% | Hold | +9.6% | Reiterated | 13.10.26on TipRanks 11:05 | — | |
| AI OpenAI Medical - Healthcare PlansOpenAI 5.2 | TipRanks - OpenAI | $408 → $466+14.2% | Hold | +12.8% | Reiterated | 13.10.26on TipRanks 11:05 | — | |
| AI Anthropic Medical - Healthcare PlansAnthropic Opus-4.6 | TipRanks - Anthropic | $395 → $442+11.9% | Hold | +7.0% | Reiterated | 13.10.26on TipRanks 11:05 | — | |
| AI Google Medical - Healthcare PlansGemini 3.1Pro | TipRanks - Google | $420 → $479+14.0% | Buy | +15.9% | Upgrade | 13.10.26on TipRanks 11:05 | — | |
| AI PerPlexity Medical - Healthcare PlansPerPlexity SonarPro | TipRanks - PerPlexity | $403 → $455+12.9% | Hold | +10.1% | Reiterated | 13.10.26on TipRanks 11:05 | — | |
| Elizabeth Anderson CFA★★★★★★★★★★#2664 · hits 55% · avg +4.4% | Evercore ISI | $480 | Buy | +16.2% | Reiterated | 13.10.26on TipRanks 10:05 | −3.0%next day +2.8% | ↗ |
| Ann Hynes★★★★★★★★★★#1003 · hits 59% · avg +8.1% | Mizuho Securities | $468 → $495+5.8% | Buy | +19.8% | Reiterated | 13.10.26on TipRanks 07:31 | −3.0%next day +2.8% | ↗ |
| A.J. Rice★★★★★★★★★★#690 · hits 61% · avg +9.8% | UBS | $405 → $495+22.2% | Hold | +19.8% | Assigned | 12.10.26on TipRanks 08:15 | +0.4%next day −3.0% | ↗ |
| David S Macdonald★★★★★★★★★★#400 · hits 63% · avg +13.2% | Truist Financial | $415 → $475+14.5% | Hold | +15.0% | Reiterated | 12.10.26on TipRanks 07:55 | +0.4%next day −3.0% | ↗ |
| John Ransom★★★★★★★★★★#681 · hits 60% · avg +10.2% | Raymond James | $520 | Buy | +25.9% | Upgrade | 12.10.26on TipRanks 07:00 | +0.4%next day −3.0% | ↗ |
| Michael Wiederhorn★★★★★★★★★★#535 · hits 59% · avg +11.3% | Oppenheimer | $405 → $475+17.3% | Buy | +15.0% | Reiterated | 09.10.26on TipRanks 08:50 | +11.0%next day +0.4% · 5 days −2.4% | ↗ |
| Michael Ha★★★★★★★★★★#10152 · hits 42% · avg −2.4% | Robert W. Baird | $390 → $596+52.8% | Buy | +44.3% | Upgrade | 09.10.26on TipRanks 05:10 | +11.0%next day +0.4% · 5 days −2.4% | ↗ |
| Ben Hendrix★★★★★★★★★★#1571 · hits 53% · avg +7.2% | RBC Capital | $415 | Hold | +0.4% | Reiterated | 07.10.26on TipRanks Oct 8 21:45 | −1.7%next day −1.9% · 5 days +8.8% | ↗ |
| Sarah James★★★★★★★★★★#2265 · hits 55% · avg +5.7% | Cantor Fitzgerald | $460 | Buy | +11.3% | Upgrade | 07.10.26on TipRanks 06:25 | −1.7%next day −1.9% · 5 days +8.8% | ↗ |
| Lance Wilkes★★★★★★★★★★#1628 · hits 63% · avg +11.3% | Bernstein | $425 | Buy | +2.9% | Reiterated | 05.10.26on TipRanks 07:31 | +3.4%next day −0.5% · 5 days +6.9% | ↗ |
| David Windley★★★★★★★★★★#769 · hits 59% · avg +9.3% | Jefferies | $624 → $420−32.7% | Buy | +1.7% | Reiterated | 30.09.26on TipRanks 11:55 | −1.2%next day −0.7% · 5 days +2.0% | ↗ |
| Stephen Baxter★★★★★★★★★★#3289 · hits 50% · avg +3.9% | Wells Fargo | $502 | Buy | +21.5% | Reiterated | 15.09.26on TipRanks 07:30 | −2.1%next day −2.6% · 5 days −8.6% | ↗ |
| Kevin Fischbeck★★★★★★★★★★#8009 · hits 57% · avg +0.1% | Bank of America Securities | — | Buy | — | Assigned | 08.09.26on TipRanks 05:16 | +0.9%next day −0.3% · 5 days −0.5% | ↗ |
| Lisa Gill★★★★★★★★★★#1237 · hits 58% · avg +9.0% | J.P. Morgan | $316 → $393+24.4% | Hold | −4.9% | Assigned | 10.08.26on TipRanks 07:30 | +0.2%next day −3.0% · 5 days −0.3% | ↗ |
| Erin Wright★★★★★★★★★★#354 · hits 64% · avg +15.1% | Morgan Stanley | $249 → $370+48.6% | Hold | −10.4% | Upgrade | 05.08.26on TipRanks Aug 4 17:00 | +0.7%next day +1.1% · 5 days +6.5% | ↗ |
| Ryan Langston★★★★★★★★★★#9454 · hits 47% · avg −0.6% | TD Cowen | $350 → $370+5.7% | Hold | −10.4% | Assigned | 31.07.26on TipRanks Jul 30 20:50 | −1.5%next day +1.5% · 5 days +2.3% | ↗ |
| Jessica Tassan★★★★★★★★★★#11189 · hits 43% · avg −3.3% | Piper Sandler | $254 → $463+82.3% | Buy | +12.1% | Upgrade | 30.07.26on TipRanks 09:45 | −1.3%next day −1.5% · 5 days −3.5% | ↗ |
| George Hill★★★★★★★★★★#1126 · hits 54% · avg +9.0% | Deutsche Bank | $441 → $436−1.1% | Buy | +5.5% | Reiterated | 30.07.26on TipRanks 08:25 | −1.3%next day −1.5% · 5 days −3.5% | ↗ |
| Scott Fidel★★★★★★★★★★#1346 · hits 64% · avg +7.9% | Goldman Sachs | $195 → $280+43.6% | Sell | −32.2% | Reiterated | 30.07.26on TipRanks 07:30 | −1.3%next day −1.5% · 5 days −3.5% | ↗ |
| Whit Mayo★★★★★★★★★★#3228 · hits 49% · avg +3.6% | Leerink Partners | $255 → $513+101.2% | Buy | +24.2% | Upgrade | 30.07.26on TipRanks 06:20 | −1.3%next day −1.5% · 5 days −3.5% | ↗ |
| Matthew Gillmor CFA★★★★★★★★★★#6184 · hits 53% · avg +2.0% | KeyBanc | — | Hold | — | Reiterated | 30.07.26on TipRanks 05:31 | −1.3%next day −1.5% · 5 days −3.5% | ↗ |
| Parker Snure★★★★★★★★★★#8410 · hits 67% · avg +1.7% | Raymond James | $425 | Hold | +2.9% | Downgrade | 30.07.26on TipRanks 05:31 | −1.3%next day −1.5% · 5 days −3.5% | ↗ |
| Jason Cassorla★★★★★★★★★★#3435 · hits 57% · avg +5.7% | Guggenheim | $269 → $471+75.1% | Buy | +14.0% | Reiterated | 29.07.26on TipRanks Jul 30 06:56 | −4.5%next day −1.3% · 5 days −6.0% | ↗ |
| David Toung★★★★★★★★★★#1098 · hits 63% · avg +9.1% | Argus Research | — | Hold | — | Reiterated | 08.12.25on TipRanks 11:40 | −0.3%next day −2.3% · 5 days +7.6% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Humana
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $422 at a price of $382 (+10.6%); now: $459 at $413 (+11.1%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 | 0 |
| Buy | 11 | 13 | 15 | 13 | 14 | 12 |
| Hold | 11 | 14 | 11 | 11 | 9 | 6 |
| Sell | 2 | 3 | 4 | 3 | 2 | 0 |
Earnings and sales forecast
Next report: 06.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-1.00 (from $-1.16 to $-0.60). Last quarter: $7.61.
Sales
Next quarter’s sales estimate — $40.9B (from $40.4B to $41.4B). Last quarter: $40.9B.
Best top-analyst consensus in the sector · Healthcare
About Humana
- CEO: James A. Rechtin
- Employees: 67,060
- Humana Building, Louisville, KY, 40202, US
- www.humana.com
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
Data from the stock’s TipRanks forecast page, read 18 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗